Skip to content

Effect of injection of methotrexate or triamcinolone in the nail for treatment of nail psoriasis

Comparison of the effect of intralesional injection of methotrexate and triamcinolone in the treatment of nail psoriasis

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20140212016557N7
Enrollment
78
Registered
2021-05-18
Start date
2021-05-22
Completion date
Unknown
Last updated
2021-05-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Nail psoriasis. Other psoriasis

Interventions

Intervention 1: Intervention group: Intralesional injection of methotrexate (Mylan factory, France) is done in the nail matrix and bed every 3 weeks for 4 sessions. Intervention 2: Control group: Intr

Sponsors

Shiraz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
16 Years to 70 Years

Inclusion criteria

Inclusion criteria: Patients between 16 and 70 years of age Clinically- or pathologically confirmed nail psoriasis that have involvement of one or more fingernails with psoriasis

Exclusion criteria

Exclusion criteria: Patients with involvement of 5 or more nails Patients who received systemic or topical medication (for nail) in the last 3 months Patients with skin involvement of more than 20% that need systemic treatment Patients with nail fungal infection History of hypersensitivity reactions to lidocaine, triamcinolone, or methotrexate Diabetic patients Pregnancy Lactation Immunocompromised patients Patients with active peptic ulcer, gastritis, ascitis, and pleural effusion Concomitant use of hepatotoxic drugs, or drugs that interfere with methotrexate metabolism Concomitant radiotherapy Active or severe infection Decreased pulmonary function Renal failure

Design outcomes

Primary

MeasureTime frame
Severity of nail involvement with psoriasis. Timepoint: At the beginning of treatment and weeks 3 ,6, 9, 12, 15, and 23. Method of measurement: modified Nail Psoriasis Severity Index (mNAPSI), measured by inspection and scoring of the severity of psoriasis features in nail matrix and bed.

Secondary

MeasureTime frame
Quality of life index. Timepoint: At the beginning and end of treatment. Method of measurement: Dermatology quality of life index questionnaire.;Pain severity during injection. Timepoint: At the beginning of treatment and weeks 3 ,6, 9, 12, 15, and 23. Method of measurement: illustrated numerical rating scale.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMozhdeh Sepaskhah

Shiraz University of Medical Sciences

sepaskhah@sums.ac.ir+98 712125239

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026